[Joseph Chen 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP o (a) o (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER (1) 333,950,485 ordinary shares 6 SHARED VOTING POWER 0 7 SOLE DISPOSITIVE POWER (1)]
[CUSIP No. 00211V106]
[Number 99.1 Announcement on Appointment of Vice President and Chief Financial Officer. SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED Wang Zhiqing President Sinopec Shanghai Petrochemical Company Limited]
[Lazard Asset Management LLC 1) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP o o 2) SEC USE ONLY 3) CITIZENSHIP OR PLACE OF ORGANIZATION: Delaware 4) NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: SOLE VOTING POWER: 1,166,576 5) SHARED VOTING POWER: - 6) SOLE DISPOSITIVE POWER]
[Number 99.1 Announcement on Appointment of Vice President and Chief Financial Officer. SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED Wang Zhiqing President Sinopec Shanghai Petrochemical Company Limited]
[Lazard Asset Management LLC 1) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP o o 2) SEC USE ONLY 3) CITIZENSHIP OR PLACE OF ORGANIZATION: Delaware 4) NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: SOLE VOTING POWER: 1,166,576 5) SHARED VOTING POWER: - 6) SOLE DISPOSITIVE POWER]
[Sinovac Reports Unaudited Third Quarter 2016 Financial Results BEIJING, Nov. 28, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter ended September 30, 2016. Mr. Weidong Yin, Chairman, Presid]
[filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be otherwise subject to t]
[Sinovac Reports Unaudited Third Quarter 2016 Financial Results BEIJING, Nov. 28, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter ended September 30, 2016. Mr. Weidong Yin, Chairman, Presid]
[filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be otherwise subject to t]
